Tag:
medical devices
Latest Headlines
Latest Headlines
In India, device companies will succeed by going local
A new PricewaterhouseCoopers report suggests that companies aren't innovating fast enough to keep up with the country's rapid evolution into a broader and more sophisticated market.
Med device companies split on social media use
About half of medical device companies have tapped social networking websites for communications, yet a lesser number of devicemakers have refined their approaches to using sites such as LinkedIn, Facebook and Twitter.
Department of Homeland Security issues device hacking warning
Some medical devices are at risk, the agency has decided, and it has issued a warning on some of those specific threats, entitled "Attack Surface: Healthcare and Public Health Sector."
Consumer group wary of industry concessions in FDA user fee bill
Consumer advocates aren't happy about the 5-year user fee re-authorization bill for the device and drug industries, which is now moving rapidly through Congress. That's because the bill is giving industries a quicker pathway to FDA approval for certain products.
Mindray grabs controlling stake in Chinese endoscope maker
The Shenzhen-based Mindray Medical ($MR) disclosed it bought a controlling stake in Optcla Medical Instrument, which is based on Hangzhou, China and makes rigid endoscopes.
UPDATED: Baxter bitten again by problems with Colleague infusion pumps
The company says it was served a subpoena in March by the SEC which wants info "related to the company's accounting treatment, financial reporting and disclosures relating to the remediation and recall of the company's Colleague and Syndeo infusion pumps," MassDevice reports.
U.K. regulators toughen focus against counterfeit devices and drugs
U.K. regulators are rolling out new policies designed to strengthen its fight against counterfeit medical devices and drugs.
(Lack of) FDA device monitoring draws new scrutiny
The FDA is facing new criticism over the lack of a dedicated monitoring system to track problems with artificial hips, pacemakers or other devices.
Covidien closes $108M bid for Newport Medical
After 6 weeks and $108 million spent, Covidien ($COV) is the proud new owner of Newport Medical Instruments in what is becoming another heady year of acquisitions for its device division.
Haemonetics taking on Pall blood-processing business lines for $550M
Haemonetics ($HAE) was busy this weekend, rolling out agreements for two strategic purchases designed to significantly boost its blood management device and technology offerings.
